OVERVIEW

Cracking the Code to Successful Stem Cell Mobilization in Multiple Myeloma is organized by i3 Health.

Dates Available:
October 8, 2024 - October 7, 2025

Statement of Need:
Multiple myeloma is the leading indication of autologous hematopoietic stem cell transplantation (ASCT) in hematologic malignancies, with high-dose therapy followed by ASCT representing a potentially curative treatment modality for eligible patients. Collecting peripheral blood stem cells (PBSCs) is an essential component of ASCT, and the collection of sufficient autologous PBSCs relies on the successful mobilization of hematopoietic stem cells from the bone marrow niche into circulation. Stem cell mobilization strategies differ in terms of stem cell yields, safety considerations, and resource utilization, and mobilization failure remains a concern in spite of the incorporation of novel agents into conventional methods. Therefore, it is crucial that clinicians apply interdisciplinary strategies to mitigate poor mobilization and optimize ASCT outcomes (Wei & Wei, 2023). In this activity, Dr. Hamza Hashmi, Assistant Attending in the Myeloma & Cell Therapy Service at Memorial Sloan Kettering Cancer Center and Assistant Professor of Clinical Medicine at Weill Cornell Medical College, will share insights into cracking the code to successful stem cell mobilization in multiple myeloma. 

Learning Objectives:
Upon completion of this activity, participants should be able to

  • Evaluate current and emerging data on stem cell mobilization regimens in patients with MM
  • Identify patients eligible for ASCT and at high risk of mobilization failure
  • Apply interdisciplinary strategies to mitigate poor mobilization and optimize ASCT outcomes

This activity will explore strategies for successful stem cell mobilization in multiple myeloma, focusing on optimizing peripheral blood stem cell collection for autologous hematopoietic stem cell transplantation (ASCT). Hamza Hashmi, MD, Assistant Attending Physician in the Myeloma & Cell Therapy Service at Memorial Sloan Kettering Cancer Center and Assistant Professor of Clinical Medicine at Weill Cornell Medical College will share insights on improving outcomes through interdisciplinary approaches and addressing mobilization challenges. Start the activity now!

Credits

Jointly Accredited Provider
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
i3 Health designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.

Physician Assistants/Associates
i3 Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 10/7/25. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Nursing Continuing Professional Development
A maximum of 0.75 ANCC contact hours may be earned by learners who successfully complete this nursing continuing professional development activity. This activity has been designated for 0.75 ANCC contact hours of pharmacology credit for Advanced Practice Registered Nurses.

Provider approved by the California Board of Registered Nursing, Provider Number 15824, for 0.75 ANCC contact hours. 

ONCC Recertification
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

ONCC review is only for designating content to be used for recertification points and is not for NCPD accreditation. NCPD programs must be formally approved for contact hours by an acceptable accreditor/approver of NCPD to be used for recertification by ONCC. If the NCPD provider fails to obtain formal approval to award contact hours by an acceptable accrediting/approval body, no information related to ONCC recertification may be used in relation to the program.

OCN®, CPHON®, CBCN®, AOCNP®, AOCNS®, and BMTCN® renewal candidates may apply 0.75 ILNA points toward:

  • Care Continuum (OCN®, CBCN®, CPHON®, AOCNP®)
  • Cellular Collection, Preparative Regimens, and Infusion (BMTCN®)
  • Early Post-Transplant Management and Education (BMTCN®)
  • Foundations of Transplant (BMTCN®)
  • Late Post-Transplant Management and Education (BMTCN®)
  • Oncologic Emergencies (OCN®, CPHON®, AOCNP®)
  • Oncology Nursing Practice (OCN®)
  • Professional Practice/Performance (BMTCN®, AOCNP®)
  • Psychosocial Dimensions of Care (AOCNP®, CPHON®, OCN®, CBCN®)
  • Roles of the APRN (AOCNP®)
  • Symptom Management, Palliative Care, Supportive Care (OCN®, CPHON®, AOCNP®)
  • Transplant Process and Infusion (BMTCN®)
  • Treatment (OCN®, CBCN®, AOCNP®, CPHON®)

Please note that some of the course content applies to multiple content areas. The numerical value above indicates the maximum amount of points that can be claimed in each domain. The total amount of ILNA points claimed may not exceed the total amount of NCPD awarded from this course.

  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 MOC
  • 0.75 AAPA
  • 0.75 Contact Hours
  • TARGET AUDIENCE

    PhysicianNursingPhysician AssistantOncologistsHealthcare ProfessionalsAdvanced Practitioner NursesNursesHematologistNurse PractitionersMedical Oncologists

    SPECIALITIES

    Hematology Hematology NurseHematology Blood and Marrow TransplantOncology

    RELATED ONLINE COURSES

    May 25, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut ...
    5 AMA PRA Category 1 Credits™
    ...
    More actions
    US$180

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$15.20

    Aug 23, 2022 - Nov 30, 2026 | Webcast

    State required course for New Jersey
    3 AMA PRA Category 1 Credits™
    ...
    More actions
    US$102